A systematic review of Chinese randomized clinical trials of SSRI treatment of depression
Conclusions:
In light of the low trial quality, the findings of a significant advantage of SSRI over TCA in terms of response rate and remission rate should be replicated by large high-quality Chinese studies.
Source: BMC Psychiatry - Latest articles - Category: Psychiatry Authors: Ying ZhangThomas BeckerYongchun MaMarkus Koesters Source Type: research
More News: Celexa | Citalopram | Clinical Trials | Databases & Libraries | Depression | Fluoxetine | Lexapro | Men | Paroxetine | Paxil | Prozac | Psychiatry | Sertraline | Study | Zoloft